🇺🇸 FDA
Pipeline program

KSH01 injection

KSH01-TCRT-01

Phase 1 small_molecule active

Quick answer

KSH01 injection for TCR-T Cells is a Phase 1 program (small_molecule) at TScan Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
TScan Therapeutics
Indication
TCR-T Cells
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials